LGALS3 and thyroid gland carcinoma: Since MAPK/ERK signaling is the most commonly studied signaling pathway in thyroid cancers [19], we examined the levels of ERK and phosphorylated ERK between thyroid cancer cells transfected with control- or Gal-3-shRNA.